Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
A3035
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NamePidilizumab (Anti-PDCD1 / PD-1 / CD279)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionPidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.
- Storage Instruction-20°C
- UNSPSC12352203